Curative Biotechnology, Inc.
CUBT
$0.0118
$0.00032.61%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -10.17% | 7.79% | -49.18% | 7.86% | 60.87% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 146.51% | -315.00% | 0.00% |
| Total Amortization of Deferred Charges | 5.44% | 200.12% | 279.91% | -3,758.33% | -131.58% |
| Total Other Non-Cash Items | 243.28% | -66.62% | 1,283.16% | -103.92% | -77.20% |
| Change in Net Operating Assets | 10.01% | 706.75% | -125.02% | 329.84% | 1,053.49% |
| Cash from Operations | 43.68% | 73.80% | -104.50% | -39.61% | -7.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -725.00% | 87.88% | -- | 100.00% | -- |
| Cash from Investing | -725.00% | 87.88% | -433.82% | -13.33% | -- |
| Total Debt Issued | -87.40% | -79.09% | 1,266.71% | -- | -- |
| Total Debt Repaid | -33.46% | 0.00% | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -- | -- | 28.94% | -29.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 323.64% | 38.43% | 26.13% | -- | -- |
| Cash from Financing | -35.38% | -84.72% | 64.17% | 23.53% | -22.73% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.19% | 49.06% | -484.42% | -1,764.86% | -97.74% |
